Tri-Valley deal activity remained strong into the end of the year.
How did Title21 go from being a small Pleasanton-based laboratory software provider, to market leader partnering with the most prestigious healthcare institutions in the world, in just a couple years? “Our technology speaks for itself, and we’re dedicated to our customers and their patients,” says Lynn Fischer, Title21’s CEO.
If you’ve been following along with our recent market outlook videos you’re probably familiar with our ever-growing concern that rising costs will impact future corporate earnings growth. One Tri-Valley startup is working to reverse this trend.